Hamed Valizadeh

1.2k citations
17 papers · 739 indexed · h-index 10
Topics
COVID-19 Clinical Research Studies (7 papers)Long-Term Effects of COVID-19 (4 papers)Extracellular vesicles in disease (2 papers)
Partner nations
IranRussiaKazakhstan

In The Last Decade

Hamed Valizadeh

16 papers receiving 729 citations

Peers

Hamed Valizadeh
Comparison fields: 5 of 97
  • Infectious Diseases 276
  • Molecular Biology 235
  • Neurology 142
  • Molecular Medicine 128
  • Immunology 98
Replace Armin Sadeghi with:
Armin Sadeghi Iran
Mahnaz Ghaebi Iran
Shihui Lin China
Samaneh Abdolmohammadi‐Vahid Iran
Sabyasachi Senapati India
Chuanjiang Wang China
Takwa Bedhiafi Qatar
Juntao Yin China
Hamed Valizadeh relative to Armin Sadeghi Iran Armin Sadeghi's profile →
Citations per field
00.5×10×13×
Armin Sadeghi · 1×
Citations per year

Countries citing papers authored by Hamed Valizadeh

Since Specialization
Citations

This map shows the geographic impact of Hamed Valizadeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hamed Valizadeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hamed Valizadeh more than expected).

Fields of papers citing papers by Hamed Valizadeh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hamed Valizadeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hamed Valizadeh. The network helps show where Hamed Valizadeh may publish in the future.

Co-authorship network of co-authors of Hamed Valizadeh

This figure shows the co-authorship network connecting the top 25 collaborators of Hamed Valizadeh. A scholar is included among the top collaborators of Hamed Valizadeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hamed Valizadeh. Hamed Valizadeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 3
2 5
3 69
4 3
5 15
6 47
7 53
8 6
9 127
10 209
11 0
12 28
13 52
14 3
15 73
16 37
17 9

About Hamed Valizadeh

Hamed Valizadeh is a scholar working on Infectious Diseases, Neurology and Obstetrics and Gynecology, having authored 17 papers that have together received 739 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (7 papers), Long-Term Effects of COVID-19 (4 papers) and Extracellular vesicles in disease (2 papers). The work is most often cited by research in Molecular Medicine (128 citations), Infectious Diseases (276 citations) and Neurology (142 citations). Hamed Valizadeh has collaborated with scholars based in Iran, Russia and Kazakhstan. Frequent co-authors include Majid Ahmadi, Leila Roshangar, Armin Sadeghi, Mahnaz Ghaebi, Ali Taghizadieh, Sanaz Abbaspour‐Aghdam, Farhad Jadidi‐Niaragh, Samaneh Abdolmohammadi‐Vahid, Haleh Mikaeili and Saeed Aslani. Their work appears in journals such as Life Sciences, European Journal of Pharmacology and Journal of Cellular Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026